Which Cancers Are Rising in Younger Adults in England?
Bowel Cancer Rates Have More Than Doubled Among Under-50s in England
In 2001, England recorded about four new bowel cancer diagnoses for every 100,000 men under 50. By 2023, the rate was just over eight. Women under 50 saw much the same change. Bowel cancer was still uncommon at those ages, but the increase appeared in both sexes and persisted even after researchers accounted for the size of the population.
That is one reason the House of Commons Science and Technology Committee called a one-off evidence session on 18 November 2026. MPs want to know which cancers are becoming more common before 50, how reliably the UK measures the change and what might explain it.
The scientific answer varies by cancer. Rising obesity probably explains part of the increase for some tumours. Changes in detection can affect how many cases doctors find. And in bowel cancer, researchers have identified a distinctive pattern of DNA damage that may date back to childhood. Scientists have yet to establish how much each factor contributes to the rise.
How Much Have Cancer Rates Risen in Younger Adults?
Cancer Research UK found that the annual rate of new cancers among UK adults aged 25 to 49 rose from 132.9 per 100,000 in 1995 to 164.6 in 2019. That is a 24% relative increase, or about 32 additional diagnoses a year for every 100,000 people in that age group.
The same figures show why age still matters so much. In 2019, the rate among people over 75 was about 2,483 per 100,000, roughly 15 times the rate among 25 to 49-year-olds. The younger group experienced the faster percentage rise. The older group still faced a much greater likelihood of receiving a diagnosis in any given year.
The UK-wide average also hides substantial differences between cancers. The World Cancer Research Fund compared English records for 2001 and 2023. Among women under 50, the bowel cancer rate rose from 3.8 to 8.3 per 100,000. The breast cancer rate rose from 42 to 47.5 per 100,000. Bowel cancer more than doubled while breast cancer rose by about 13%. Yet breast cancer added slightly more diagnoses per 100,000 women because it started from a much higher level.
Those two comparisons answer different questions. The bowel cancer figures tell researchers where the pattern of disease has shifted particularly sharply. The breast cancer figures tell health services why even a modest percentage increase can mean more women needing appointments, surgery and follow-up care.
What Can MPs Learn by Comparing Younger and Older Patients?
One of the scientists listed for the parliamentary session, Professor Montse García-Closas of the Institute of Cancer Research, helped lead a study that made precisely that comparison. Her team examined English cancer registrations from 2001 to 2019. They identified 11 cancers with established behavioural risk factors for which diagnosis rates had increased among adults aged 20 to 49.
For nine of those cancers, rates had also risen among people aged 50 and above. That changes the search for an explanation. If kidney cancer is rising across generations, for example, researchers have reason to investigate changes that affect several age groups, including how often people undergo scans that might reveal a tumour.
Bowel and ovarian cancer stood apart. Over the full study period, their rates increased in the younger group alone. Even these two cancers followed different paths. The researchers found signs that ovarian cancer incidence among younger women had stabilised or fallen towards the end of the period. A rise measured across two decades can conceal a more recent change in direction.
Parliament’s first panel brought together specialists in population health and NHS England’s National Disease Registration Service. Its remit included deaths and survival as well as diagnoses. Each measure answers a different question. If a scan finds a tumour two years earlier, a patient can appear to survive two years longer after diagnosis even if they die at exactly the same age. Looking at cancer deaths per head of population gives MPs a way to test what an apparent improvement in survival means. The same issue arises when researchers assess whether an experimental blood test for ovarian cancer would benefit patients.
How Much of the Rise Can Weight and Diet Explain?
An established cause of cancer can explain why people develop the disease without explaining why more people are developing it now. Smoking illustrates the point. Tobacco can continue to cause thousands of cancers after smoking becomes less common, because the damage can take years to appear. To explain an upward trend, scientists need to know how exposure changed, who experienced it and when.
The English research team compared cancer registrations with population surveys covering smoking, alcohol, body weight, physical activity and aspects of diet. Of the established risks they examined, obesity was the one that had clearly become more common. There are plausible biological reasons for a contribution. Higher levels of body fat can alter hormone levels, affect how the body responds to insulin and contribute to long-term inflammation.
The team then estimated how bowel cancer rates in women aged 20 to 49 had changed between 2005 and 2019. The portion they attributed to higher body mass index rose from 0.9 to 1.7 cases per 100,000. The remaining portion rose from 6.7 to 10.0. In absolute terms, the larger increase occurred in the part their model could not attribute to higher BMI.
These are population estimates. They cannot tell a woman why she developed bowel cancer. They do, however, put a limit on one popular explanation. Weight is a credible contributor, and a substantial rise still needs explaining. The team also found that several familiar risks, including smoking and alcohol consumption, had remained stable or declined over the periods examined. Simply listing unhealthy habits misses one of the most revealing findings in the English data.
What Did Scientists Find Inside Younger Patients’ Bowel Tumours?
A study published in Nature in 2025 took a different approach. Researchers examined the DNA of 981 bowel cancers from 11 countries. They looked for distinctive patterns of mutations that could reveal something about the exposures a cell had experienced years before it became a tumour.
Two patterns linked to colibactin, a substance produced by certain gut bacteria, were 3.3 times as common in tumours from people diagnosed before 40 as in those diagnosed after 70. The researchers also found evidence that the damage occurred early in the tumour’s development. Some of the changes affected a gene called APC, which helps regulate the growth of cells lining the bowel.
The timing makes the finding particularly interesting. A tumour diagnosed at 38 may carry a record of damage that began long before the patient chose their adult diet or developed symptoms. That gives scientists a reason to investigate childhood exposures that a questionnaire completed at diagnosis could easily miss.
There is a crucial limit to the figure of 3.3. Everyone in the comparison already had bowel cancer. The researchers measured how often the DNA patterns appeared in their tumours. They could not use that comparison to calculate a healthy child’s future cancer risk. To connect the finding to rising national rates, scientists would also need evidence that relevant exposure had become more common, or had begun earlier, in successive generations.
What Does This Mean for Someone Under 50?
For anyone worried about a change in their own body, the NHS advice is straightforward. Speak to a GP about a new lump, unusual bleeding, unexplained weight loss or a change in bowel habits that persists or gets worse. These symptoms commonly have other causes. A person experiencing them can seek advice at any age, without waiting for a routine screening invitation.
For MPs, the most revealing question may be narrower than “Why is cancer rising?” England has identified a disease whose diagnosis rate more than doubled in younger men and women, whose age pattern differs from several other cancers and whose tumours can preserve evidence of early damage. The next advance would be to connect those observations: to establish which exposures changed between generations and whether those changes account for the extra bowel cancers now appearing before 50.
Sources
UK Parliament — Early Onset Cancer: What Does the Science Tell Us? — The remit, date and witnesses for the one-off evidence session.
Cancer Research UK — Cancer Rates Rising in Under-50s — UK diagnosis rates for adults aged 25 to 49 and the comparison with people over 75.
World Cancer Research Fund — Early-Onset Cancer Data — English incidence figures by cancer type and sex.
García-Closas and colleagues — Temporal Trends in Behavioural Risk Factors for Cancers With Rising Incidence in Younger Adults — The English registry study comparing age groups and estimating the contribution of established risk factors.
Díaz-Gay and colleagues — Geographic and Age Variations in Mutational Processes in Colorectal Cancer — The international study of colibactin-linked DNA damage in bowel tumours.
NHS — Cancer — Symptoms and guidance on when to speak to a GP.
Next Reads
Can a Blood Test Spot Changes That Come Before Ovarian Cancer? What the New Study Found — Why finding a biological signal early and showing that a test saves lives require different kinds of evidence.
Why Are We Studying ‘Forever Chemicals’ in People’s Bodies — What measuring an environmental exposure can tell researchers about health risks.
Injectable Nanoantennas Show Promise Against Brain Cancer in Preclinical Tests — How scientists assess a promising laboratory finding before testing whether it can help patients.